A diabetes drug may have benefits beyond lower blood sugar in patients with HIV. New research from Washington University School of Medicine in St. Louis suggests the drug may prevent cardiovascular problems because it works to reduce inflammation that is linked to heart disease and stroke in these patients. The drug both improved metabolism and reduced inflammation in HIV-positive adults on antiretroviral therapy.
15 May 2015 | Eurekalert Medicine & Health
Researchers have begun enrolling participants in a multicenter international clinical trial to test whether a statin can reduce the risk of heart disease in people with HIV infection, who are up to twice as likely as people without HIV infection to have heart disease.
16 April 2015 | Eurekalert Inf Dis
People with HIV on antiretroviral therapy (ART) with controlled viral loads may benefit from using statins earlier than typically prescribed to control high cholesterol, according to two studies presented last week at CROI 2015.
06 March 2015 | BETA blog
Previously reported increased risk of heart attacks among HIV-positive individuals has been largely reversed in recent years for Kaiser Permanente's California patients, according to a study published in the current online issue of Clinical Infectious Diseases. The adjusted risk ratio for heart attacks among HIV-positive study participants went from an 80 percent increased risk in 1996 to no increased risk in 2010-2011. Reported first on Aidsmap at http://www.aidsmap.com/Heart-attack-risk-in-people-with-HIV-may-be-falling-but-not-in-women/page/2834402/ .
19 January 2015 | Eurekalert
HIV-infected adults are at a higher risk for developing heart attacks, kidney failure and cancer. But, contrary to what many had believed, the researchers say these illnesses are occurring at similar ages as adults who are not infected with HIV.
10 December 2014 | Science Daily
A retrospective analysis using the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Guidelines and Pooled Cohort Equations (PCEs) for acute myocardial infarction (AMI) and cardiovascular disease (CVD) risk found that the PCE scores were a much better predictor of 10-year CVD risk than the Framingham risk score in a cohort of more than 15,000 HIV-positive veterans on antiretroviral therapy, according to a presentation at ICAAC 2014, made by Henning Drechsler, M.D., of the University of Texas Southwestern Medical Center.
22 October 2014 | The Body
HIV-positive adults had a 40% higher ischemic stroke rate than matched people without HIV. But stroke rates were similar in HIV-negative people and HIV-positives with a high CD4 count or low viral load.
03 September 2014 | International AIDS Society
People with HIV treated at a major university are less likely to receive medications to support heart health than those who do not have HIV.
02 September 2014 | AIDSMeds
As effective treatments for HIV become more widely available in low-income and middle-income countries, there's an urgent need to assess and manage health risks in the growing number of people living with HIV. An update on non-communicable diseases among HIV-positive populations in low-income and middle-income countries appears as a supplement to in JAIDS: Journal of Acquired Immune Deficiency Syndromes. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
14 August 2014 | Eurekalert Medicine & Health
The only drug to receive Food and Drug Administration approval for reduction of the abdominal fat deposits that develop in some patients receiving antiviral therapy for HIV infection may also reduce the incidence of fatty liver disease in such patients. Massachusetts General Hospital investigators report that six months of daily injections of tesamorelin significantly reduced fat in the liver without affecting glucose metabolism.
19 July 2014 | Eurekalert Medicine & Health